
UPL Q3 FY24 Earnings Call Analysis
Revenue, margin, capex, fundraise and order book outlook from management commentary.
Management growth scorecard
Revenue
Category 4
Margin
Category 3
Fundraise
Yes
Order
N/A
Capex
Yes
2 of 4 growth signals are positive.
Full analysisRevenue guidance
Category 4- Farm gate demand remains strong or above last year levels in most markets with positive grower margins, supporting yield and efficiency improvements.
- Anticipated market balancing as distributor destocking subsides by mid-calendar year 2024, especially in North America, Europe, and Brazil.
- Expectation of sequential margin improvement and recovery in sales volumes starting FY25, with Q4 FY24 seen as better than Q3.
- Growth momentum continues in differentiated and sustainable products, which now account for a larger portfolio share.
- Latin America (outside Brazil), Rest of World, China, Turkey, and India platforms performing well, driving volume growth.
- New product launches in crops like corn, sugarcane, and paddy expected to boost sales in next 2-3 quarters.
- Slightly above current plant capacity utilization forecast for FY25, indicative of volume growth.
- Industry-wide destocking pressures alleviating, with pricing now stabilizing post-patent active ingredients since Q2.
See what UPL management said on margin guidance — free account, 30 seconds.
Fundraise plans
Yes- UPL Limited has announced a rights issue of up to USD 500 million to augment cash flows.
- The company is also exploring capital raise options in its platforms.
- Proceeds from these initiatives will be used to repay debt.
- The board has approved the rights issue of up to USD 500 million, expected to be announced by the end of February 2024.
- The company aims to reduce net debt from approximately USD 3.7 billion (Dec 2023) to around USD 2.5 billion through operating cash flow and capital raises.
- Additional expected debt reduction of USD 400-500 million is anticipated post-rights issue.
See what UPL management said on order book — free account, 30 seconds.
Capex plans
YesTrack UPL — get its next earnings analysis in your feed
How does UPL rank vs peers in Fertilizers & Agrochemicals?
Pro featureHow does UPL rank in Fertilizers & Agrochemicals?
Compare UPL against every Fertilizers & Agrochemicals company (Q3 FY24) on revenue, margins and earnings-call signals.
Continue your research
What UPL's management said in earlier quarters
Others in Fertilizers & Agrochemicals this season
- Madhya Bharat Agro Products (Q2 FY27)
Q2 FY27 Revenue: ₹715 crore, up 59% YoY (Page 12, Chairman’s Quote) . Key investor presentation takeaways from Madhya Bharat Agro Products Ltd's Q2 FY27 investo
- Dhansa Labs (Q2 FY27)
1,864 crores during H1 FY27. Key results statement takeaways from Dhansa Labs Ltd's Q2 FY27 results statement — and how it ranks against sector peers.
- Aristo Bio-Tech (Q2 FY27)
1,168.88 lakh, approximate operating margin is about 5.9% for the quarter. Key results statement takeaways from Aristo Bio-Tech & Lifescience Ltd's Q2 FY27 resu
- Krishana Phoschem (Q2 FY27)
Q2 FY27 Revenue: ₹703 crore, a 16% year-on-year (YoY) increase (Page 11). Key investor presentation takeaways from Krishana Phoschem Ltd's Q2 FY27 investor pres